| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |